Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2026-05-17 @ 2:12 PM
Study NCT ID:
NCT06665256
Status:
RECRUITING
Last Update Posted:
2025-10-28
First Post:
2024-10-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2 Study of Rapcabtagene Autoleucel in Myositis
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Idiopathic Inflammatory Myopathies | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Chimeric Antigen Receptor T cells (CAR-T) | View |
| None | rapcabtagene autoleucel | View |
| None | idiopathic inflammatory myopathies (IIM) | View |
| None | dermatomyositis | View |
| None | Anti-Synthetase Syndrome | View |
| None | Immune-Mediated Necrotizing Myopathy | View |
| None | Interstitial Lung Disease | View |